Our news

Lhasa Limited is pleased to announce the latest data release for members of the Lhasa Intermediates Consortium. This pre-competitive data sharing initiative facilitates the anonymous sharing of genetic toxicity data for common intermediates and compounds containing functional groups of interest, helping to advance scientific understanding and improve predictive toxicology.

Lhasa Limited is pleased to announce the release of Vitic Q3D, an innovative in silico tool designed to harmonise ICH Q3D assessments using proprietary elemental impurities data.

Lhasa Limited is pleased to announce the latest release of Derek Nexus (version 6.4.2) and Sarah Nexus (version 5.0.0) – expert-knowledge and statistically driven decision-support tools designed to help scientists make confident, evidence-based safety assessments.

This pre-competitive data sharing initiative facilitates anonymous sharing of proprietary data on the level of nitrites in common excipients, solvents and reagents.

Lhasa Limited are pleased to announce the latest version of Zeneth, with impactful updates to align with the requirements in forced degradation study guidelines and improvement in prediction confidence.

Lhasa Limited is pleased to announce the release of new data to the Vitic Elemental Impurities database. This pre-competitive data sharing initiative facilitates anonymous sharing of analytical data on the levels of trace elements in excipients.   

Lhasa Limited is excited to announce the latest update to the Vitic Complex Nitrosamines database. This pre-competitive data sharing initiative promotes the anonymous exchange of genetic toxicology data on structurally complex nitrosamines, primarily Ames data.

Lhasa Limited is delighted to announce the release of new pharmaceutical excipient data to our Vitic Excipients database.   This pre-competitive data sharing initiative facilitates anonymous sharing of excipient and vehicle toxicity data, providing members with proprietary formulation information to establish safe limits for pharmaceutical excipients while strengthening regulatory submissions.

Improving offerings across the chemical, biotechnology, pharmaceutical, and most notably, the cosmetics industry. Lhasa is delighted to announce the acquisition of Molecular Networks GmbH and Altamira, LLC.

Lhasa Limited is delighted to announce a new partnership with CTR Scientific, marking a joint commitment to advancing chemical safety assessments in Mexico.